By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte Corporation 

Maxygen, Inc. 

Intergen Company 

Company News
Sandoz, Inc. Stays In New Jersey, Moves To Former Home Of Novo Nordisk A/S (NVO) 7/10/2014 7:49:47 AM
FDA Approves Novo Nordisk A/S (NVO)'s NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness 7/7/2014 12:23:56 PM
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014 7:58:34 AM
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014 8:58:05 AM
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014 8:49:29 AM
Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014 8:35:04 AM
Novo Nordisk A/S (NVO) And NBA Legend Dominique Wilkins Spotlight Full-Court Approach To Type 2 Diabetes Management 6/25/2014 7:44:40 AM
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014 7:28:01 AM
Positive New Phase 3a Data On Novo Nordisk A/S (NVO)'s Liraglutide 6/23/2014 6:13:55 AM
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/17/2014 9:12:00 AM